Loading...
P-003. Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience
INTRODUCTION: The prevelance of HCV in Turkey is 0.5–1.0%. According to Turkish Society of Nephrology registry, anti-HCV positivity rate was 6.94% in chronic hemodialysis patients in 2013. Beyond the liver-related mortality, HCV infection increases all kind of mortality in hemodialysis patients. In...
Saved in:
| Published in: | Turk J Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Turkish Society of Gastroenterology
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7021023/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2019.09 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|